C3is Financials
C3is (CISS) reported $34.8M in revenue for fiscal year 2025, down 17.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Balance-sheet repair and thin core operating profit are the key mechanics behind this year's healthier-looking financial picture.
Between FY2024 and FY2025, cash conversion reversed: a-$2.7M net loss produced$25.0M of operating cash flow, then a$10.5M net profit produced only$4.0M . That mismatch matters because FY2025 operating income was only$1.4M , far below net income, so the cleaner bottom line overstates how much profit the core business itself produced.
The big FY2025 balance-sheet change was liability reduction: total liabilities fell from
Recent free cash flow also reflects light reinvestment: FY2025 capital spending was just
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of C3is's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
C3is has an operating margin of 3.9%, meaning the company retains $4 of operating profit per $100 of revenue. This strong profitability earns a score of 72/100, reflecting efficient cost management and pricing power. This is down from 23.8% the prior year.
C3is's revenue declined 17.8% year-over-year, from $42.3M to $34.8M. This contraction results in a growth score of 65/100.
C3is carries a low D/E ratio of 0.04, meaning only $0.04 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 6.21, C3is holds $6.21 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 93/100.
C3is converts 11.1% of revenue into free cash flow ($3.8M). This strong cash generation earns a score of 90/100.
C3is's ROE of 11.0% shows moderate profitability relative to equity, earning a score of 57/100. This is up from -3.9% the prior year.
C3is scores 0.82, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
C3is passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, C3is generates $0.38 in operating cash flow ($4.0M OCF vs $10.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
C3is earns $162.49 in operating income for every $1 of interest expense ($1.4M vs $8K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
C3is generated $34.8M in revenue in fiscal year 2025. This represents a decrease of 17.8% from the prior year.
C3is's EBITDA was $7.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 51.6% from the prior year.
C3is reported $10.5M in net income in fiscal year 2025. This represents an increase of 481.1% from the prior year.
Cash & Balance Sheet
C3is generated $3.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 83.6% from the prior year.
C3is held $617K in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
C3is's operating margin was 3.9% in fiscal year 2025, reflecting core business profitability. This is down 19.9 percentage points from the prior year.
C3is's net profit margin was 30.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 36.6 percentage points from the prior year.
C3is's ROE was 11.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 14.9 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
C3is invested $162K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 90.0% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
CISS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 |
|---|---|---|---|
| Revenue | $34.8M-17.8% | $42.3M+47.2% | $28.7M |
| Operating Income | $1.4M-86.4% | $10.1M-3.5% | $10.4M |
| Interest Expense | $8K-35.9% | $13K+193.1% | $4K |
| Net Income | $10.5M+481.1% | -$2.7M-129.6% | $9.3M |
| EPS (Diluted) | $3.98 | -$351.58 | $18911.99 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Income Tax.
CISS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 |
|---|---|---|---|
| Total Assets | $98.5M-2.0% | $100.5M+5.3% | $95.5M |
| Current Assets | $20.8M+27.5% | $16.3M-19.6% | $20.3M |
| Cash & Equivalents | $617K-86.7% | $4.6M+567.4% | $695K |
| Inventory | $1.3M+48.4% | $884K+28.3% | $689K |
| Total Liabilities | $3.4M-88.4% | $29.1M-27.0% | $39.9M |
| Current Liabilities | $3.4M-82.0% | $18.7M-53.2% | $39.9M |
| Total Equity | $95.1M+33.3% | $71.4M+28.5% | $55.5M |
| Retained Earnings | $4.5M+1645.1% | $257K-96.9% | $8.3M |
Not reported in any period shown, so not listed: Accounts Receivable, Goodwill, Long-Term Debt.
CISS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 |
|---|---|---|---|
| Operating Cash Flow | $4.0M-84.0% | $25.0M+342.9% | $5.6M |
| Capital Expenditures | $162K-90.0% | $1.6M-62.3% | $4.3M |
| Free Cash Flow | $3.8M-83.6% | $23.4M+1643.9% | $1.3M |
| Investing Cash Flow | -$6.5M-380.6% | -$1.4M+89.1% | -$12.4M |
| Financing Cash Flow | -$1.5M+92.4% | -$19.7M-362.9% | $7.5M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CISS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 |
|---|---|---|---|
| Operating Margin | 3.9%-19.9pp | 23.8%-12.5pp | 36.3% |
| Net Margin | 30.1%+36.6pp | -6.5%-38.8pp | 32.3% |
| Return on Equity | 11.0%+14.9pp | -3.9%-20.6pp | 16.7% |
| Return on Assets | 10.6%+13.4pp | -2.7%-12.5pp | 9.7% |
| Current Ratio | 6.21+5.3x | 0.87+0.4x | 0.51 |
| Debt-to-Equity | 0.04-0.4x | 0.41-0.3x | 0.72 |
| FCF Margin | 11.1%-44.2pp | 55.2%+50.6pp | 4.7% |
Not reported in any period shown, so not listed: Gross Margin.
Similar Companies
Where C3is Ranks
Frequently Asked Questions
What is C3is's annual revenue?
C3is (CISS) reported $34.8M in total revenue for fiscal year 2025. This represents a -17.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is C3is's revenue growing?
C3is (CISS) revenue declined by 17.8% year-over-year, from $42.3M to $34.8M in fiscal year 2025.
Is C3is profitable?
Yes, C3is (CISS) reported a net income of $10.5M in fiscal year 2025, with a net profit margin of 30.1%.
What is C3is's EBITDA?
C3is (CISS) had EBITDA of $7.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is C3is's operating margin?
C3is (CISS) had an operating margin of 3.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is C3is's net profit margin?
C3is (CISS) had a net profit margin of 30.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is C3is's return on equity (ROE)?
C3is (CISS) has a return on equity of 11.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is C3is's free cash flow?
C3is (CISS) generated $3.8M in free cash flow during fiscal year 2025. This represents a -83.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is C3is's operating cash flow?
C3is (CISS) generated $4.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are C3is's total assets?
C3is (CISS) had $98.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are C3is's capital expenditures?
C3is (CISS) invested $162K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is C3is's current ratio?
C3is (CISS) had a current ratio of 6.21 as of fiscal year 2025, which is generally considered healthy.
What is C3is's debt-to-equity ratio?
C3is (CISS) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is C3is's return on assets (ROA)?
C3is (CISS) had a return on assets of 10.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is C3is's Altman Z-Score?
C3is (CISS) has an Altman Z-Score of 0.82, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is C3is's Piotroski F-Score?
C3is (CISS) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are C3is's earnings high quality?
C3is (CISS) has an earnings quality ratio of 0.38x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can C3is cover its interest payments?
C3is (CISS) has an interest coverage ratio of 162.49x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is C3is?
C3is (CISS) scores 77 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.